BRAF and neoplasm: While KRAS-mutated tumours showed less infiltration of immune cells compared to wild-type KRAS tumours, in particular cytotoxic T cells and Th1 cells, BRAF-mutated tumours showed a higher infiltration of these immune cells compared to wild-type BRAF tumours.